United States· US:72065-001_1a581a6b-8813-42ed-8892-21c2341b62c0
Keveyis
A medicinal product containing dichlorphenamide, registered in United States by Xeris Pharmaceuticals, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DICHLORPHENAMIDE
- Manufacturer
- Xeris Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc117206500101100 TABLET in 1 BOTTLE (72065-001-01)
- ndc1172065-001-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dichlorphenamide in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4ba8689-1e94-4ef1-8596-a98f7c303fbd GET /v1/drugs/f4ba8689-1e94-4ef1-8596-a98f7c303fbd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50",
"substance": "DICHLORPHENAMIDE",
"productndc": "72065-001",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA011366",
"marketing_category": "NDA"
}See everything about dichlorphenamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.